TECH options flow: unusual options activity in Bio-Techne Corp.

Updated 19 November 2026, 22:00 ET

Over the last week the tape recorded 8 unusual options prints in Bio-Techne Corp. (TECH), $417K of tracked premium, leaning firmly bearish. Bullish premium was $0 against $164K bearish; $417K went into calls and $0 into puts, a put call ratio of 0.00. The largest print was $164K of TECH 15 Dec 2028 $40 calls on 17 November 2026, swept at bid. The last session with prints, 19 November 2026, added 7 prints and $253K of premium. TECH closed at $72.70 on 19 November 2026, down 0.1%.

This week's unusual flow

Unusual prints8
Tracked premium$417K
Net premium-$164K
Bullish premium$0
Bearish premium$164K
Call premium$417K
Put premium$0
P/C ratio0.00
Sweeps12%
Size over OI7
Whale prints0
High conviction0

Prints from 17 November 2026 to 19 November 2026, 2 sessions. Delayed tier: every print is shown twenty minutes after it executed, and the page is rebuilt after each session.

Net premium is bullish minus bearish premium. The put call ratio is put premium divided by call premium, weighted by money rather than by contract count. Sweeps is the share of prints executed across several exchanges at once. Read the guide: Reading the Pulse.

Largest prints of the week

DateContractTypeSizeOpen int.PremiumExecutionSentimentTier
17 Nov 2026TECH 15 Dec 2028 $40 callsSweep501,208$164KAt bidBearishNotable
19 Nov 2026TECH 15 Jan 2027 $25 callsTrade81$38KAt midpointNeutral
19 Nov 2026TECH 15 Jan 2027 $25 callsTrade81$38KAt midpointNeutral
19 Nov 2026TECH 15 Jan 2027 $25 callsTrade81$38KAt midpointNeutral
19 Nov 2026TECH 15 Jan 2027 $25 callsTrade81$38KAt bidNeutral
19 Nov 2026TECH 15 Jan 2027 $25 callsTrade81$38KAt bidNeutral
19 Nov 2026TECH 15 Jan 2027 $25 callsTrade71$33KAt bidNeutral
19 Nov 2026TECH 15 Jan 2027 $25 callsTrade61$29KAt midpointNeutral

Size above open interest means the trade opened a position larger than everything that existed in the contract the night before. Above ask and below bid are the most aggressive executions. Read the guide: Size versus open interest.

Where the money is aimed

ExpiryPrintsPremiumCalls shareNet premium
15 Jan 20277$253K100%+$0
15 Dec 20281$164K100%-$164K

The most premium, $253K, is aimed at the 15 Jan 2027 expiry.

A print in a contract expiring this week is a view about the next few days, often about a known event; a print months out is a different kind of statement. Read the guide: 0DTE options flow.

The last session, 19 November 2026

Prints7
Premium$253K
Net premium+$0
P/C ratio0.00
Sweeps0%
DateContractTypeSizeOpen int.PremiumExecutionSentimentTier
19 Nov 2026TECH 15 Jan 2027 $25 callsTrade81$38KAt midpointNeutral
19 Nov 2026TECH 15 Jan 2027 $25 callsTrade81$38KAt midpointNeutral
19 Nov 2026TECH 15 Jan 2027 $25 callsTrade81$38KAt midpointNeutral
19 Nov 2026TECH 15 Jan 2027 $25 callsTrade81$38KAt bidNeutral
19 Nov 2026TECH 15 Jan 2027 $25 callsTrade81$38KAt bidNeutral

Every print in TECH with its full detail, the live tape, one tap filters and saved screeners: open TECH in Options Sentiment Screener.

Price

Last close$72.70
Day-0.07%
1 week-0.19%
1 month+0.08%
3 months+0.53%
1 year+25.02%
52 week high$72.88
52 week low$43.20
Volume3,322,614
Market cap$11.4B

The live quote and the price chart sit beside the ticker's flow in the app: open TECH in Options Sentiment Screener.

Analysts

The most recent analyst targets on file, from 7 firms, have a median of $73, 0.4% above the last close.

Calls bought at a strike above the average target are a bet that the analysts are too cautious; puts far below the price in a name they like are protection or a strong disagreement. Read the guide: Reading one ticker's flow.

About Bio-Techne Corp.

Exchange
Nasdaq
Sector
Health Care
Industry
Pharmaceutical Products
Headquarters
MINNEAPOLIS, Minnesota
Website
bio-techne.com

Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services. Protein Sciences segment provides biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy. Diagnostics and Genomics segment provides diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market.

In the same sector

Flow pages for other Health Care names in the S&P 500:

LLY Eli Lilly & Co.JNJ Johnson & JohnsonABBV AbbVie Inc.UNH UnitedHealth Group Inc.MRK Merck & Co. Inc.TMO Thermo Fisher Scientific Inc.AMGN Amgen Inc.GILD Gilead Sciences, Inc.

Learn

The live tape for TECH with every print's execution detail, one tap filters for calls, puts, sweeps and 0DTE, saved screeners and, for Realtime subscribers, push alerts and no delay. The same screen is in the iOS and Android apps.

Open TECH in Options Sentiment Screener